Detecting HEK293 residual DNA contamination in your cell or gene therapy products
9 May 2022

Cell and gene therapies begin their development with the help of a host cell line, but before the product can be administered to a patient, any trace of the host cell DNA must be removed to avoid oncogenic effects.

In this application note, BIO-RAD introduces its ddPCR technology, a fast, precise, and reproducible molecular detection method for HEK293 residual DNA contamination that provides high sensitivity and a quantitative readout that reports genome copies per reaction.